IRONWOOD PHARMACEUTICALS INC

IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001446847

Price chart

Open-market purchases and sales by IRWD insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jul 9, 20264:32 PM ETJul 7, 2026Silver RonaldPFO & PAOSSaleClass A Common Stock−127.89K$4.52−$578.06K313.68K−29.0%SEC10b5-1
Jun 17, 2026Jun 16, 2026McHugh JulieDirectorSSaleClass A Common Stock−21.57K$3.73−$80.46K250.75K−7.9%SEC10b5-1
Mar 17, 2026Mar 17, 2026DENNER ALEXANDER JDirectorSSaleClass A Common Stock−6.73M$3.0502−$20.53M9.19M−42.3%SEC
Feb 25, 2026Feb 23 – Feb 24, 2026Martini Gregory S.Chief Financial OfficerSSaleClass A Common Stock−21.94K$3.7317−$81.89K160.6K−12.0%SEC
Feb 25, 2026Feb 23 – Feb 24, 2026John MinardoChief Legal OfficerSSaleClass A Common Stock−36.49K$3.7317−$136.18K363.89K−9.1%SEC

The largest institutional positions in IRWD at the end of Q2 2026.

Institutions holding IRWD in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.17,788,557$74.89M0.00%+4,425,627+33.1%Added
ARMISTICE CAPITAL, LLC13,932,000$58.65M1.62%−1,096,000−7.3%Reduced
Sarissa Capital Management LP9,188,635$38.68M21.75%00.0%Unchanged
STATE STREET CORP8,809,601$37.09M0.00%+1,352,657+18.1%Added
BANK OF AMERICA CORP /DE/8,683,803$36.56M0.00%+8960.0%Added